AACR 2026: New clues emerge behind rise of early-onset colorectal cancer
Industry Buzz
We don't yet have a validated way to identify which younger patients without family history need earlier evaluation. Until we do, the clinical approach should be simple: Take symptoms in young patients very seriously.
—Michael Bass, MD
Certainly diets high in meats and fat and low in fiber appear to be associated with higher cancer risk, and there is a suggestion that obesity and diabetes are also playing a role.
—William Chapman Jr, MD
Cases of early-onset colorectal cancer continue to rise. Incidence in adults under 50 has increased steadily over the past two decades, with a near doubling since the 1990s.[]
Studies being reported at the 2026 AACR annual meeting are adding new details on biology, risk, and survivorship.
Data gaps and disparities remain a central issue
Research into early-onset colorectal cancer still lacks diverse, patient-reported data, limiting understanding of risk and outcomes across populations.
One analysis highlights limitations in current datasets. In a pilot cohort of 60 patients, 32% had early-onset disease. These patients were more often Hispanic, 58% vs 32%, and more likely to receive care in safety-net settings.[]
Discussing the gaps in stratification for younger patients, Michael Bass, MD, a board-certified gastroenterologist, said, “We don’t yet have a validated way to identify which younger patients without family history need earlier evaluation. Until we do, the clinical approach should be simple: take symptoms in young patients seriously. Rectal bleeding, iron-deficiency anemia, unexplained weight loss, or persistent changes in bowel habits in a 32-year-old deserve the same urgency as in a 62-year-old.”
Cohort-driven disease
Recent research has considered modern-day environmental exposures as potential drivers behind the spike in early-onset colorectal cancer among young adults.
Birth cohort effects are emerging as a dominant signal. Individuals born in the 1990s have a four-fold higher risk of early-onset colorectal cancer compared to those born in the 1960s.[]
One group of researchers has focused on a possible correlation with glyphosate exposure. They analyzed over 108,000 death certificates of people under 50 who died from colorectal cancer and mapped those locations against nationwide agricultural data. They found that individuals living in counties with the highest use of the herbicide glyphosate had a 10% greater risk of dying from the disease compared to those in areas with the lowest use.[]
These patterns point to exposures that accumulate early in life rather than late-stage risk factors alone.
Dr. Bass elaborates on this pattern, stating, “Every generation born after roughly 1950 carries higher colorectal cancer risk than the one before. That tells you something changed in the environment, not the genome.”
Microbiome disruption
Kyle Eldredge, DO, a board-certified surgeon specializing in colorectal surgery, highlights the role of "Westernized" microbiomes (from diets high in processed foods and low in fiber), which create a pro-inflammatory environment that may trigger early carcinogenesis.
In a preclinical model involving mice, antibiotic exposure during specific early-life developmental windows led to persistent alterations in the gut microbiome, as well as to increased pro-inflammatory bacterial strains and higher tumor burden.[]
Dr. Bass said, “The exposures that keep surfacing are childhood antibiotic use, early obesity, ultra-processed diets low in fiber, and sugary drinks starting in adolescence. No single factor explains the trend, but they all converge on the gut microbiome. Early-life antibiotic exposure can durably reshape the microbial communities that develop during childhood in ways that persist into adulthood.”
However, WashU Medicine colorectal surgeon William Chapman Jr, MD, MPHS, expresses some skepticism. “It seems logical that some environmental exposures are to blame for the rapid increase in cancer incidence among younger people,” he says.
“However, much debate remains about which factors are truly driving this trend. Certainly diets high in meats and fat and low in fiber appear to be associated with higher cancer risk, and there is a suggestion that obesity and diabetes are also playing a role," Dr. Chapman says. "However, it is very difficult to identify one or several discrete exposures given the broad spectrum of people and lifestyles who are suffering from these cancers."
Detection remains a major gap
Younger patients often present at later stages due to lack of routine screening. As explained by Dr. Bass, “We have lowered the screening age to 45, which was important. But many of the early-onset cases I see are in their 30s.”
Early tumors often behave more aggressively, making early detection non-negotiable. Vikram Tarugu, MD, a board-certified gastroenterologist, notes, “Younger patients often present with more aggressive, mucinous histology and advanced-stage disease, as these tumors often bypass the traditional "slow" polyp-to-cancer progression.”
Both Dr. Tarugu and Dr. Eldredge emphasize the "cognitive gap" that occurs in dealing with younger patients, whereby symptoms in patients under 45 (like rectal bleeding) are frequently misdiagnosed as hemorrhoids, leading to dangerous delays in treatment.
New work being presented at AACR describes a non-invasive electrochemical immunosensor designed to detect early colorectal cancer biomarkers.[] The sensor demonstrated strong analytical performance, with a detection limit of 0.71 ng/µL and high linearity across clinically relevant ranges. Biomarkers such as CCNB1 and MCM10 were found to be elevated in early-onset colorectal cancer, particularly in Hispanic patients.
The authors propose that, “This non-invasive, low-cost electrochemical probe has strong potential to expand screening and improve early detection of CRC, especially among younger and underserved populations, thereby improving the survival rates.”[]
Survivorship and modifiable factors
Post-diagnosis management is becoming an area of focus. In a cohort of 424 early-onset colorectal cancer patients with a mean follow-up of 5.4 years, vitamin D levels were associated with survival outcomes. Patients with sufficient vitamin D levels had a hazard ratio of 0.36 compared to those with deficiency. Even patients with insufficient levels showed improved survival, with a hazard ratio of 0.34.[]
These findings suggest that modifiable factors may influence long-term outcomes in early-onset disease.
Discussing the impact of modified risk factors, Dr. Bass states, “Physical activity after diagnosis is associated with lower cancer-specific mortality in multiple studies. I discuss it with every patient. Dietary patterns matter, too: higher fiber, less processed meat, more plants. I check vitamin D levels and replete deficiency, though the evidence that supplementation directly changes cancer outcomes is still developing. The bigger conversation is metabolic health. Obesity, insulin resistance, and inflammation are all modifiable. For younger patients with potentially decades of survivorship ahead, optimizing these factors is worth discussing at every visit.”
Dr. Chapman adds, “We do not have data suggesting that any one intervention reduces risk. However, maintaining an active lifestyle with high fiber intake certainly won’t hurt!”